Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INOVIQ LTD Capital/Financing Update 2016

Jun 16, 2016

65112_rns_2016-06-16_0c7741db-6aee-4de0-b8b9-ffe5c2fdba9e.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

(ACN 009 070 384)

==> picture [155 x 46] intentionally omitted <==

10 June 2016

The Manager Australian Securities Exchange 152-158 St George’s Terrace PERTH WA 6000

Dear Sir/Madam

The Company advises that the capital structure on re-quotation is as follows:

Shares Performance Shares
Ordinary Shares 322,493,350
Ordinary Shares (escrowed for24 Months from the date ofreinstatement to OfficialQuotation) 229,503,236
Performance Shares (escrowedfor 24 Months from the date ofreinstatement to OfficialQuotation) 217,003,236

Yours sincerely

==> picture [94 x 31] intentionally omitted <==

Pauline Collinson Company Secretary

BARD1 Life Sciences Limited (ABN 59 009 070 384) Suite B1, Tempo Building, 431 Roberts Road, Subiaco WA 6008 Tele: +618 93819550 Facsimile: +618 9388 7559